Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 2
2010 1
2011 1
2012 1
2014 1
2015 2
2016 1
2018 1
2019 2
2020 1
2021 1
2022 1
2023 5
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.
van Baarle FLF, van de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF, van den Bergh WM, Demandt AMP, Kerver ED, Jansen AJG, Westerweel PE, Arbous SM, Determann RM, van Mook WNKA, Koeman M, Mäkelburg ABU, van Lienden KP, Binnekade JM, Biemond BJ, Vlaar APJ. van Baarle FLF, et al. Among authors: makelburg abu. N Engl J Med. 2023 May 25;388(21):1956-1965. doi: 10.1056/NEJMoa2214322. N Engl J Med. 2023. PMID: 37224197 Clinical Trial.
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease.
Jalink M, Jacobs CF, Khwaja J, Evers D, Bruggeman C, Fattizzo B, Michel M, Crickx E, Hill QA, Jaeger U, Kater AP, Mäkelburg ABU, Breedijk A, Te Boekhorst PAW, Hoeks MPA, de Haas M, D'Sa S, Vos JMI. Jalink M, et al. Among authors: makelburg abu. Blood Adv. 2024 Jun 11;8(11):2622-2634. doi: 10.1182/bloodadvances.2024012585. Blood Adv. 2024. PMID: 38507742 Free PMC article.
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
EINSTEIN–PE Investigators; Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. EINSTEIN–PE Investigators, et al. N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449293 Free article. Clinical Trial.
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial.
Burggraaf-van Delft JLI, van Rein N, Bemelmans RHH, van den Berg JK, Bruggeman CY, Cloos-van Balen M, Coppens M, Eefting M, Ende-Verhaar Y, van Es N, van Guldener C, de Jong WK, Kleijwegt F, Koster T, Kroon C, Kuipers S, Leentjens J, Luijten D, Mairuhu ATA, Meijer K, van de Ree MA, Roos R, Schrover I, Swart-Heikens J, van der Velden AWG, van den Akker-van Marle EM, le Cessie S, Geersing GJ, Middeldorp S, Huisman MV, Klok FA, Cannegieter SC; L-TRRiP investigators. Burggraaf-van Delft JLI, et al. BMJ Open. 2024 Mar 23;14(3):e078676. doi: 10.1136/bmjopen-2023-078676. BMJ Open. 2024. PMID: 38521524 Free PMC article.
Anti-IFC antibodies in a patient with CHAPLE syndrome: Implications for blood management.
Minović I, Schipperus MR, Mäkelburg ABU, Meijer K, Lukens MV, Kootstra-Ros JE, van der Heide F, Abbasova I, de Kleine RHJ, Meekers JH, Mulder AB. Minović I, et al. Among authors: makelburg abu. Br J Haematol. 2023 Jan;200(1):109-112. doi: 10.1111/bjh.18509. Epub 2022 Oct 10. Br J Haematol. 2023. PMID: 36216787 No abstract available.
Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.
van Baarle FLF, van de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF, van den Bergh WM, Demandt AMP, Kerver ED, Jansen AJG, Westerweel PE, Arbous MS, Determann RM, van Mook WNKA, Koeman M, Mäkelburg ABU, van Lienden KP, Vlaar APJ, Biemond BJ. van Baarle FLF, et al. Among authors: makelburg abu. Am J Hematol. 2023 Nov;98(11):E305-E308. doi: 10.1002/ajh.27053. Epub 2023 Aug 21. Am J Hematol. 2023. PMID: 37605361 Free article. No abstract available.
Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis.
Punt M, van Leusden F, Bloemenkamp K, Coppens M, Driessens M, Heubel-Moenen F, Lely T, Mäkelburg A, Nieuwenhuizen L, Haitjema S, van Solinge W, Saes J, Schols S, Schutgens R, Eikenboom J, Kruip M, van Galen K. Punt M, et al. Among authors: makelburg a. Res Pract Thromb Haemost. 2024 Jul 14;8(5):102508. doi: 10.1016/j.rpth.2024.102508. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39165610 Free PMC article.
Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS).
Fischer K, Lassila R, Peyvandi F, Gatt A, Gouw SC, Hollingsworth R, Lambert T, Kaczmarek R, Carbonero D, Makris M; European HAemophilia Safety Surveillance (EUHASS) participants. Fischer K, et al. Res Pract Thromb Haemost. 2024 May 27;8(4):102461. doi: 10.1016/j.rpth.2024.102461. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 39026659 Free PMC article.
21 results